Dr. Reddy's Laboratories launches drug to treat chronic constipation

29 Oct 2024 Evaluate

Dr Reddy's Laboratories has launched a first-in-class drug to treat chronic constipation. The company will market the drug under the brand name BixiBat in India. The launch follows approval granted to the company by the Central Drugs Standard Control Organisation (CDSCO). Dr Reddy's is the first company to receive approval for and launch such a drug (Elobixibat) in India.

Elobixibat acts by inhibiting the reabsorption of bile acids from the ileum, thus increasing their concentration in the colonic lumen, leading to increased bowel movements due to stimulation of both colonic motility and fluid secretion irrespective of the transit speed. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1279.65 6.70 (0.53%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×